On February, 11 VistaGen Therapeutics, Inc. (VTGN) EPS Estimated At $-0.30 – Z Tribune

On February, 11 VistaGen Therapeutics, Inc. (VTGN) EPS Estimated At $-0.30 Z Tribune

On February, 11 is expected VistaGen Therapeutics, Inc. (NASDAQ:VTGN)’s earnings report, Zacks reports. Analysts forecast 25.00 % diference or $-0.30 from …